Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Shares Outstanding (Weighted Average) (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $103.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 10.7% to $103.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.2 million, a 10.7% increase, with the full-year FY2025 number at $103.2 million, up 10.7% from a year prior.
  • Shares Outstanding (Weighted Average) was $103.2 million for Q4 2025 at Day One Biopharmaceuticals, roughly flat from $103.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $103.2 million in Q4 2025 to a low of $58.4 million in Q1 2022.
  • A 4-year average of $82.4 million and a median of $83.2 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 23.31% in 2023, then increased 10.7% in 2025.
  • Day One Biopharmaceuticals' Shares Outstanding (Weighted Average) stood at $65.5 million in 2022, then grew by 21.85% to $79.8 million in 2023, then increased by 16.87% to $93.2 million in 2024, then increased by 10.7% to $103.2 million in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Shares Outstanding (Weighted Average) are $103.2 million (Q4 2025), $103.1 million (Q3 2025), and $103.1 million (Q2 2025).